| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| 50mg |
|
||
| Other Sizes |
|
| ln Vitro |
Yakuchinone A had IC50 values of 14.75, 31.73, 21.71, 26.07, 11.50, and 11.96 μM on A375P, B16F1, B16F10, A549, MCF-7, and HT-29 cell lines, respectively [1]. 16 h) has the ability to decrease the production of IL-17 in EL4 (mouse cell line) cells in a quantitatively-dependent way, with an IC50 value of 11.5 μM [2].
|
|---|---|
| ln Vivo |
In the autoimmune encephalitis (EAE) model, yakuchinone A (50 mg/kg, ip, daily, 14 days) can reduce the EAE symptoms [1].
|
| Animal Protocol |
Animal/Disease Models: Female C57BL/6 mice [1] ]
Doses: 50 mg/kg Route of Administration: intraperitoneal (ip) injection, daily, 14 days Experimental Results: EAE scores were Dramatically diminished from the 9th to the 15th day after the onset of EAE. |
| References |
|
| Additional Infomation |
1-(4'-hydroxy-3'-methoxyphenyl)-7-phenyl-3-heptanone is a ketone that is heptan-3-one substituted by a 4-hydroxy-3-methoxyphenyl group at position 1 and a phenyl group at position 7. Isolated from in Alpinia oxyphylla, it exhibits antineoplastic and inhibitory activities against COX-1, COX-2 and NO synthase. It has a role as a metabolite, a cyclooxygenase 1 inhibitor, a cyclooxygenase 2 inhibitor, an EC 1.14.13.39 (nitric oxide synthase) inhibitor and an antineoplastic agent. It is a monomethoxybenzene, a member of phenols and a ketone.
Yakuchinone-A has been reported in Alpinia oxyphylla with data available. |
| Molecular Formula |
C20H24O3
|
|---|---|
| Molecular Weight |
312.40276
|
| Exact Mass |
312.173
|
| Elemental Analysis |
C, 76.89; H, 7.74; O, 15.36
|
| CAS # |
78954-23-1
|
| PubChem CID |
133145
|
| Appearance |
Colorless to off-white liquid
|
| Density |
1.095g/cm3
|
| Boiling Point |
495.8ºC at 760 mmHg
|
| Flash Point |
174.3ºC
|
| Index of Refraction |
1.559
|
| LogP |
4.315
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
9
|
| Heavy Atom Count |
23
|
| Complexity |
336
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
O=C(CCCCC1C=CC=CC=1)CCC1C=C(OC)C(O)=CC=1
|
| InChi Key |
TXELARZTKDBEKS-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C20H24O3/c1-23-20-15-17(12-14-19(20)22)11-13-18(21)10-6-5-9-16-7-3-2-4-8-16/h2-4,7-8,12,14-15,22H,5-6,9-11,13H2,1H3
|
| Chemical Name |
1-(4-hydroxy-3-methoxyphenyl)-7-phenylheptan-3-one
|
| Synonyms |
Yakuchinone-A
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~100 mg/mL (~320.10 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (8.00 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (8.00 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (8.00 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.2010 mL | 16.0051 mL | 32.0102 mL | |
| 5 mM | 0.6402 mL | 3.2010 mL | 6.4020 mL | |
| 10 mM | 0.3201 mL | 1.6005 mL | 3.2010 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
